Out of the 161 genes involved in enriched pathways between BD and FS found in this study, 129 (80%) were found to be differentially expressed in breast cancer (Fig. 3), including significantly higher expression of Runx2 and Skp2 in both the BD and breast cancer groups (Table S2). The gene discussed is SKP2; the disease is Behcet disease.